Anhedonia Predicts Poorer Recovery Among Youth With Selective Serotonin Reuptake Inhibitor Treatment-Resistant Depression Article

McMakin, Dana L, Olino, Thomas M, Porta, Giovanna et al. (2012). Anhedonia Predicts Poorer Recovery Among Youth With Selective Serotonin Reuptake Inhibitor Treatment-Resistant Depression . JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 51(4), 404-411. 10.1016/j.jaac.2012.01.011

Open Access

cited authors

  • McMakin, Dana L; Olino, Thomas M; Porta, Giovanna; Dietz, Laura J; Emslie, Graham; Clarke, Gregory; Wagner, Karen Dineen; Asarnow, Joan R; Ryan, Neal D; Birmaher, Boris; Shamseddeen, Wael; Mayes, Taryn; Kennard, Betsy; Spirito, Anthony; Keller, Martin; Lynch, Frances L; Dickerson, John F; Brent, David A

sustainable development goals

authors

publication date

  • April 1, 2012

published in

keywords

  • ACUTE ANTIDEPRESSANT TREATMENT
  • ADOLESCENT DEPRESSION
  • BRAIN
  • COGNITIVE-BEHAVIORAL THERAPY
  • COST-EFFECTIVENESS
  • Life Sciences & Biomedicine
  • MODERATORS
  • Pediatrics
  • Psychiatry
  • Psychology
  • Psychology, Developmental
  • REMISSION
  • RESIDUAL SYMPTOMS
  • Science & Technology
  • Social Sciences
  • TREATMENT RESPONSE
  • VENLAFAXINE
  • adolescence
  • clinical trial
  • cognitive-behavioral therapy
  • depression
  • treatment-resistant

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 404

end page

  • 411

volume

  • 51

issue

  • 4